Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Vijaya Diagnostic CentreBOM:543350 +2.97%87 PS Ratio is 16.75 as of Aug. 11, 2026, which is 29% above its 10-year median of 12.95. GuruFocus rates BOM:543350 with a GF Score™ of 87/100 and a GF Value™ of ₹1,241.09 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 200 Medical Diagnostics & Research companies, Vijaya Diagnostic Centre ranks worse than 90% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Vijaya Diagnostic Centre's share price is ₹1392.75.
Vijaya Diagnostic Centre's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 was ₹83.16. Hence, Vijaya Diagnostic Centre's PS Ratio for today is 16.75.
Warning Sign:
Vijaya Diagnostic Centre Ltd stock PS Ratio (=16.75) is close to 1-year high of 17.43.
The historical rank and industry rank for Vijaya Diagnostic Centre's PS Ratio or its related term are showing as below:
BOM:543350'
s PS Ratio Range Over the Past 10 Years
Min: 7.28 Med: 12.95 Max: 19.95
Current: 16.75
During the past 8 years, Vijaya Diagnostic Centre's highest PS Ratio was 19.95. The lowest was 7.28. And the median was 12.95.
BOM:543350's PS Ratio is ranked worse than 90% of 200
companies
in the Medical Diagnostics & Research industry
Industry Median: 2.79
vs BOM:543350: 16.75
During the past 8 years, Vijaya Diagnostic Centre's highest 3-Year average Revenue per Share Growth Rate was 20.80% per year. The lowest was 10.50% per year. And the median was 13.70% per year.
Vijaya Diagnostic Centre (BOM:543350) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Vijaya Diagnostic Centre's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vijaya Diagnostic Centre PS Ratio vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Vijaya Diagnostic Centre's PS Ratio distribution charts can be found below:
* The bar in red indicates where Vijaya Diagnostic Centre's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Vijaya Diagnostic Centre's Share Price of today is ₹1392.75. Vijaya Diagnostic Centre's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹83.16.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Vijaya Diagnostic Centre (BOM:543350) has a PS Ratio of 16.75 as of Aug. 11, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Vijaya Diagnostic Centre and its competitors. This is 29% above median its historical median of 12.95. Over the past decade, Vijaya Diagnostic Centre's PS Ratio has ranged from 7.28 to 19.95. According to the industry distribution chart, Vijaya Diagnostic Centre ranks #180 out of 200 companies in the Medical Diagnostics & Research industry, placing it in the top 90%.
Is Vijaya Diagnostic Centre's PS Ratio too high?
Vijaya Diagnostic Centre's current PS Ratio of 16.75 is 29% above median its 10-year median of 12.95. Over the past 10 years, this metric has ranged from a low of 7.28 to a high of 19.95. The Medical Diagnostics & Research industry median PS Ratio is 2.79. Vijaya Diagnostic Centre's value of 16.75 is 500.4% above this industry median. Based on the distribution chart, Vijaya Diagnostic Centre ranks #180 out of 200 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, Vijaya Diagnostic Centre has a GF Score™ of 87/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Vijaya Diagnostic Centre's PS Ratio compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Vijaya Diagnostic Centre ranks #180 out of 200 companies for PS Ratio. This places Vijaya Diagnostic Centre in the lower half of its industry. The industry median PS Ratio is 2.79. Vijaya Diagnostic Centre's value of 16.75 is 500.4% above this benchmark. Historically, Vijaya Diagnostic Centre's own PS Ratio has ranged from 7.28 to 19.95 over the past decade. While the company's 10-year median is 12.95 vs. the industry median of 2.79, Vijaya Diagnostic Centre has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Medical Diagnostics & Research company?
The median PS Ratio among Medical Diagnostics & Research companies is 2.79, based on 200 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vijaya Diagnostic Centre's current PS Ratio of 16.75 is 500.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Vijaya Diagnostic Centre and its competitors. For the Medical Diagnostics & Research industry, the median PS Ratio is 2.79 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vijaya Diagnostic Centre's current PS Ratio is 16.75, which is 29% above median its own 10-year median of 12.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vijaya Diagnostic Centre stock overvalued right now?
Based on GuruFocus' analysis, Vijaya Diagnostic Centre (BOM:543350) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹1,241.09, compared to a current price of ₹1,392.75 — trading 12.2% above its estimated fair value. The current PS Ratio is 16.75, which is 29% above median its 10-year median of 12.95 and 500.4% above the Medical Diagnostics & Research industry median of 2.79. Vijaya Diagnostic Centre's overall GF Score™ is 87/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Vijaya Diagnostic Centre (BOM:543350), the current PS Ratio is 16.75 as of Aug. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vijaya Diagnostic Centre (BOM:543350) Overvalued in 2026?
Based on GuruFocus' analysis, Vijaya Diagnostic Centre stock appears to be overvalued.
The current stock price of ₹1,392.75 is trading 12.2% above its estimated GF Value™ of ₹1,241.09.
GuruFocus considers Vijaya Diagnostic Centre to be Modestly Overvalued.
Key valuation signals for BOM:543350:
PS Ratio: 16.75 (29% above median its 10-year median of 12.95)
GF Value™: ₹1,241.09 vs. price of ₹1,392.75 (12.2% above fair value)
Industry Position: 500.4% above the Medical Diagnostics & Research median (#180 of 200)
No single metric tells the full story. See the BOM:543350 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vijaya Diagnostic Centre Ltd operates a diagnostic chain in Southern India. The company offers a one-stop solution for pathology and radiology testing services. It provides routine tests, specialized pathology tests, basic tests, and radiology tests. The company also offers a broad spectrum of customized health and wellness packages to its customers. The company's revenue comes from many diagnostic centers, where high-volume sales drive its earnings. The Company operates within India. The company's operations fall within a single business segment, which is Diagnostic Services.
87GF Score
Get the complete analysis for BOM:543350
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543350 has been successfully added to your 
